News Ultragenyx Announces Positive Multi-Year Durability Data from Ongoing Phase 1/2 Gene Therapy Studies and Data on HeLa 3.0 Manufacturing Platform at American Society of Gene & Cell Therapy 2021 Annu May 14, 2021 Posted by Ultragenyx
News Asymmetrex Discusses a Near Horizon for Stem Cell Dosage in Stem Cell Therapy and Gene Therapy Clinical Trial Supply Chains May 11, 2021
News Patterns Paper Shows Benefits of Modeling Complicated Small Datasets Using Unconventional, Quantum Computing-inspired Algorithms May 11, 2021
News Integration of Mcule’s purchasable compound library in Blaze™ virtual screening platform provides greater chemical diversity for outsourced projects May 11, 2021 Posted by Cresset
News Biological Specialty Company Opens New Blood Donor Center in HealthStar Physicians Practice May 10, 2021 Posted by BioIVT
News Asymmetrex Will Discuss the Impact of Its Technology for Dosing Therapeutic Stem Cells May 06, 2021
